Osiris/Genzyme Anticipates Approval Of Stem Cell Therapy Prochymal By 2010
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Osiris begins the FDA submission process for its mesenchymal stem cell therapy Prochymal this quarter, making a late-2009 approval of the world's first stem cell therapy a possibility if the agency grants a six-month review, and a first-cycle approval